OI may serve for research purposes as a simple and inexpensive indicator of evolving AD pathology. Details here.
New Parkinson disease studies offer insights into topics such as LRRK2 G2019S transgene activity, preclinical drug development, and neuroprotection in Parkinson disease.
Too many—or too few—pounds—could be a factor in migraine pathogenesis. Details here.
Seven new drugs were approved for treatment of neurological disorders, including Parkinson disease, multiple sclerosis, and amyotrophic lateral sclerosis.
A host of neuropsychiatric disorders are intrinsic to Parkinson disease or occur as a complication of the dopaminergic therapies. Here's what to look for.
What are the risks of anti-seizure meds in pregnancy? Benefits?
New studies shed light on topics such as nonencephalic pain and headache chronicity; benign childhood epilepsy with centrotemporal spikes and social cognition; and causal triggers of Alzheimer disease onset.
Adherence is a major concern for clinicians across all disciplines. Even the most effective treatment will not be successful if the patients does not adhere to the prescribed treatment strategy. Inside learn more about the problem and ways to maximize adherence.
Jobs associated with higher economic status appear to be risk factors for these neurologic disorders.
These apps are designed to improve treatment adherence, language skills, symptom tracking, communication, and other helpful functions.